Botanical species · safety record

Curculigo orchioides

The EFSA Compendium of Botanicals holds 11 constituent measurements and 1 adverse-effect record for Curculigo orchioides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Curculigo orchioides Gaertn.

11Constituent measurements

1Safety records

8Cited sources

114Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 114 licensed products naming Curculigo orchioides as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
decoction

Source material stated

New material
Rhizoma
Rhizome
Rhizome(s)
Root
Root and Rhizome
Root and rhizome
Root extract

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cardiac glycosides	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Lignans	Roots and other underground parts	Solvent extraction	—	UHPLC-MS-MS	Resolve DOI
Lignans	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Pregnane derivatives	Roots and other underground parts	Solvent extraction	—	Chromatographic tests	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	Resolve DOI
Calcium oxalate	Roots and other underground parts	Solvent extraction	—	Histometrical standard tests	No resolvable identifier
Gallic acid	Roots and other underground parts	Solvent extraction	3.54 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Lycorine	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Uterus	Roots and other underground parts	—	Human (as organism)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Patil, A., Koli, S., Patil, D.A., Narayane, V., Phatak, A.V. Evaluation of effect of aqueous slurry of curculigo orchioides Gaertn. rhizome in streptozotocin-induced diabetic rats. Journal of Pharmacy Research, 2013, vol. 7, no. 8, p. 747-753. DOI
Shrikumar, S., Athem, M., Sukumar, M., Ravi, T.K. A HPTLC method for standardization of Curculigo orchioides rhizomes and its marketed formulation using gallic acid as standard. Indian journal of pharmaceutical sciences, 2005, vol. 67, no. 6, p. 721-724.
He, Yongjing., Dong, Xin., Jia, Xiaoxuan., Li, Mei., Yuan, Tingting., Xu, Hongtao., Qin, Luping., Han, Ting., Zhang, Qiaoyan. Qualitative and quantitative analysis on chemical constituents from Curculigo orchioides using ultra high performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry . Journal of pharmaceutical and biomedical analysis, 2015, vol. 102, p. 236-245. DOI
Asif, M. A review on phytochemical and ethnopharmacological activities of Curculigo orchioides. Mahidol University Journal of Pharmaceutical Sciences, 2012, p. 1-10.
Ajesh, T.P., Krishnaraj, M.V., Prabu, M., Kumuthakalavalli, R. Herbal abortifacients used by Mannan tribes of Kerala, India. International Journal of PharmTech Research, 2012, vol. 4, no. 3, p. 1015-1017.
Patil, A.G., Koli, S.P., Patil, D.A., Phatak, A.V., Chandra, N. Pharmacognostic evaluation and hptlc fingerprint profile of Curculigo orchioides Gaertn. Rhizomes. International Journal of Pharma and Bio Sciences, 2012, vol. 3, no. 3, p. P101-P111.
XU, JP., XU, RS. CYCLOARTANE-TYPE SAPOGENINS AND THEIR GLYCOSIDES FROM CURCULIGO-ORCHIOIDES. PHYTOCHEMISTRY, 1992, vol. 31, no. 7, p. 2455-2458. DOI
Jiao, Wei., Chen, Xiaozhen., Wang, Haibo., Lu, Runhua., Shao, Huawu. A new hepatotoxic triterpenoid ketone from Curculigo orchioides. FITOTERAPIA, 2013, vol. 84, p. 1-5. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature